JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 50:1677-1684, doi:10.1016/j.jacc.2007.04.100 (Published online 6 October 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2007.04.100v1
50/17/1677    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Payne, T. R.
Right arrow Articles by Huard, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Payne, T. R.
Right arrow Articles by Huard, J.
Related Collections
Right arrowRelated Articles

PRECLINICAL STUDIES

A Relationship Between Vascular Endothelial Growth Factor, Angiogenesis, and Cardiac Repair After Muscle Stem Cell Transplantation Into Ischemic Hearts

Thomas R. Payne, PhD*,{ddagger},§, Hideki Oshima, MD, PhD*,§, Masaho Okada, MD*,§, Nobuo Momoi, MD{dagger}, Kimimasa Tobita, MD{dagger}, Bradley B. Keller, MD{dagger}, Hairong Peng, MD, PhD*,§ and Johnny Huard, PhD*,{ddagger},§,||,*

* Stem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
{dagger} Pediatric Cardiovascular Research Program, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
{ddagger} Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania,
§ Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania
|| Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, Pennsylvania

Manuscript received January 5, 2007; revised manuscript received April 3, 2007, accepted April 22, 2007.

* Reprint requests and correspondence: Dr. Johnny Huard, 3705 5th Avenue, 4100 Rangos Research Center, Pittsburgh, Pennsylvania 15213. (Email: jhuard{at}pitt.edu).

Objectives: We investigated whether vascular endothelial growth factor (VEGF) was associated with the angiogenic and therapeutic effects induced after transplantation of skeletal muscle-derived stem cells (MDSCs) into a myocardial infarction (MI).

Background: Because very few MDSCs were found to differentiate into new blood vessels when injected into the heart, the mechanism underlying the occurrence of angiogenesis after MDSC transplantation is currently unknown. In the present study, we used a gain- or loss-of-VEGF function approach with skeletal MDSCs engineered to express VEGF or soluble Flt1, a VEGF-specific antagonist, to identify the involvement of VEGF in MDSC transplantation-induced neoangiogenesis.

Methods: Vascular endothelial growth factor- and soluble Flt1-engineered MDSCs were injected into an acute MI. Angiogenesis and cardiac function were evaluated by immunohistochemistry and echocardiography.

Results: Both control and VEGF-overexpressing MDSCs induced angiogenesis, prevented adverse cardiac remodeling, and improved function compared with saline-injected hearts. However, these therapeutic effects were diminished in hearts transplanted with MDSCs expressing soluble Flt1 despite successful cell engraftment. In vitro experiments demonstrated that MDSCs increased secretion of VEGF in response to hypoxia and cyclic stretch (likely conditions in ischemic hearts), suggesting that transplanted MDSCs release VEGF in vivo.

Conclusions: Our findings suggest that VEGF is essential for the induction of angiogenesis and functional improvements observed after MDSC transplantation for infarct repair.

Abbreviations and Acronyms
  FS = fractional shortening
  fskMyHC = fast skeletal myosin heavy chain
  LV = left ventricle/ventricular
  MDSC = muscle-derived stem cell
  MI = myocardial infarction
  nLacZ = nuclear-localized LacZ
  PBS = phosphate-buffered saline
  sFlt1 = soluble Flt1
  VEGF = vascular endothelial growth factor


Related Articles

Skeletal Muscle-Derived Stem Cell Transplantation: Angiogenesis Is Required for Improved Left Ventricular Function
H. Kirk Hammond
J. Am. Coll. Cardiol. 2007 50: 1685-1687. [Full Text] [PDF]

Skeletal Muscle-Derived Stem Cell Transplantation: Angiogenesis Is Required for Improved Left Ventricular Function
H. Kirk Hammond
J. Am. Coll. Cardiol. 2007 50: 1685-1687. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
L. L. Johnson, L. Schofield, T. Donahay, M. Bouchard, A. Poppas, and R. Haubner
Radiolabeled Arginine-Glycine-Aspartic Acid Peptides to Image Angiogenesis in Swine Model of Hibernating Myocardium
J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 500 - 510.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 490 - 512.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. K. Hammond
Skeletal Muscle-Derived Stem Cell Transplantation: Angiogenesis Is Required for Improved Left Ventricular Function
J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1685 - 1687.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.